Immunogen, Inc.
SEC CIK 855654 · IMGN · last insider filing 2024-02-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mccluski Stephen C | Director | filed 2007–2024 |
| Mitchell Dean J | Director | filed 2012–2024 |
| Wallace Richard John | Director | filed 2007–2024 |
| Peterson Kristine | Director | filed 2012–2024 |
| Goldberg Mark Alan | Director | filed 2011–2024 |
| Arbuckle Stuart A | Director | filed 2018–2024 |
| Enyedy Mark J | Director · Chief Executive Officer | filed 2016–2024 |
| Thackray Helen M. | Director | filed 2021–2024 |
| Mccain Tracey L | Director | filed 2021–2024 |
| Junius Daniel M | Director · Chief Financial Officer | filed 2006–2018 |
| Pien Howard H | Director | filed 2007–2018 |
| Villafranca Joseph J | Director | filed 2006–2018 |
| Onetto Nicole | Director | filed 2006–2015 |
| Skaletsky Mark B | Director | filed 2006–2012 |
| Sayare Mitchel | Director · Chief Executive Officer | filed 2006–2011 |
| Carter David Warren | Director | filed 2006–2010 |
| Blattler Walter | Director · Executive Vice President | filed 2006–2007 |
| Feiner Stuart | Director | filed 2006–2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wingrove Theresa | VP of Regulatory Affairs | filed 2011–2024 |
| Vasconcelles Michael | EVP R&D & MEDICAL AFFAIRS | filed 2023–2024 |
| Char Daniel | SVP & CHIEF LEGAL OFFICER | filed 2022–2024 |
| Coen Stacy Ann | SVP & Chief Business Officer | filed 2020–2024 |
| Lentini Renee | VP & PRIN ACCTG OFFICER | filed 2021–2024 |
| White Lauren | SVP, CFO and PFO | filed 2023–2024 |
| Kalofonos Isabel | SVP & CHIEF COMMERCIAL OFFICER | filed 2023–2024 |
| Berkenblit Anna | VP & Chief Medical Officer | filed 2016–2023 |
| Altschuller Susan | SVP and CFO | filed 2020–2022 |
| Harrington-Smith Kristen | SVP & Chief Commercial Officer | filed 2021–2022 |
| Ryll Thomas | VP, Technical Operations | filed 2017–2021 |
| Foster David G | V.P.-Fin., Prin. Acctg. Off. | filed 2018–2021 |
| Barrows Craig | Vice-President,General Counsel | filed 2010–2020 |
| Mckee Blaine H. | EVP & Chief Business Officer | filed 2018–2019 |
| Gregory Richard J. | Executive VP & CSO | filed 2015–2019 |
| Johnston David Brannon | Chief Financial Officer | filed 2014–2018 |
| Williams Peter J. | VP, Business Development | filed 2009–2017 |
| Lambert John | Senior Vice President | filed 2006–2016 |
| Poole Sandra | Senior VP, Tech Operations | filed 2014–2016 |
| Morris Charles Q | Executive VP & CDO | filed 2012–2016 |
| Harrison Ellie | VP & Chief HR Officer | filed 2014–2016 |
| O'Leary James J | Vice President | filed 2008–2014 |
| Perry Gregory D | Chief Financial Officer | filed 2009–2013 |
| Cadden Suzanne | VP, Regulatory & Quality | filed 2009–2009 |
| Tagliamonte John | VP, Business Development | filed 2007–2008 |
| Ryan Pauline JEN | SVP Corporate Devlp & Ops | filed 2006–2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.